Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system

Journal of Immunology

Volumn 185, Issue 2, 2010, Pages 1258-1264

  Khorooshi, Reza ^a   Owens, Trevor ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; INTERFERON; INTERFERON RECEPTOR; INTERFERON REGULATORY FACTOR 7; INTERFERON REGULATORY FACTOR 9; MESSENGER RNA; STAT1 PROTEIN; ALPHA BETA INTERFERON RECEPTOR; AUTACOID; CXCL10 PROTEIN, MOUSE; GLIAL FIBRILLARY ACIDIC PROTEIN; IRF7 PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE; STAT1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; DENTATE GYRUS; ENTORHINAL CORTEX; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOFLUORESCENCE; INFLAMMATION; INJURY; KNOCKOUT MOUSE; LEUKOCYTE MIGRATION; MACROPHAGE; MICROGLIA; MOUSE; NERVE FIBER TRANSECTION; NONHUMAN; PRIORITY JOURNAL; SENSORY NERVE; SIGNAL TRANSDUCTION; ANIMAL; BRAIN INJURY; C57BL MOUSE; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LEUKOCYTE; METABOLISM; MOUSE MUTANT; MOUSE STRAIN; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD11B; BLOTTING, WESTERN; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM; CHEMOKINE CXCL10; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATION MEDIATORS; INTERFERON REGULATORY FACTOR-7; INTERFERON TYPE I; LEUKOCYTES; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; RECEPTOR, INTERFERON ALPHA-BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 77955499638     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901753     Document Type: Article

References (47)

1. Jones, T. B., E. E. McDaniel, and P. G. Popovich. 2005. Inflammatory-mediated injury and repair in the traumatically injured spinal cord. Curr. Pharm. Des. 11: 1223-1236.
2. Schwartz, M. 2003. Macrophages and microglia in central nervous system injury: are they helpful or harmful? J. Cereb. Blood Flow Metab. 23: 385-394.
3. Pineau, I., and S. Lacroix. 2009. Endogenous signals initiating inflammation in the injured nervous system. Glia 57: 351-361.
4. Larsen, P. H., T. H. Holm, and T. Owens. 2007. Toll-like receptors in brain development and homeostasis. Sci. STKE 2007: pe47.
5. Theofilopoulos, A. N., R. Baccala, B. Beutler, and D. H. Kono. 2005. Type I interferons (a/b) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-336.
6. Prakash, A., E. Smith, C. K. Lee, and D. E. Levy. 2005. Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J. Biol. Chem. 280: 18651-18657.
7. Schindler, C., D. E. Levy, and T. Decker. 2007. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282: 20059-20063.
8. Honda, K., H. Yanai, A. Takaoka, and T. Taniguchi. 2005. Regulation of the type I IFN induction: a current view. Int. Immunol. 17: 1367-1378.
9. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777. (Pubitemid 44739521)
10. Ousman, S. S., J. Wang, and I. L. Campbell. 2005. Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J. Virol. 79: 7514-7527.
11. Prinz, M., H. Schmidt, A. Mildner, K. P. Knobeloch, U. K. Hanisch, J. Raasch, D. Merkler, C. Detje, I. Gutcher, J. Mages, et al. 2008. Distinct and non-redundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 28: 675-686.
12. Teige, I., A. Treschow, A. Teige, R. Mattsson, V. Navikas, T. Leanderson, R. Holmdahl, and S. Issazadeh-Navikas. 2003. IFN-b gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 170: 4776-4784. (Pubitemid 36519987)
13. Finsen, B., M. B. Jensen, N. D. Lomholt, I. V. Hegelund, F. R. Poulsen, and T. Owens. 1999. Axotomy-induced glial reactions in normal and cytokine transgenic mice. Adv. Exp. Med. Biol. 468: 157-171.
14. Ladeby, R., M. Wirenfeldt, I. Dalmau, R. Gregersen, D. García-Ovejero, A. Babcock, T. Owens, and B. Finsen. 2005. Proliferating resident microglia express the stem cell antigen CD34 in response to acute neural injury. Glia 50: 121-131. (Pubitemid 40695266)
15. Babcock, A. A., M. Wirenfeldt, T. Holm, H. H. Nielsen, L. Dissing-Olesen, H. Toft-Hansen, J. M. Millward, R. Landmann, S. Rivest, B. Finsen, and T. Owens. 2006. Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation. J. Neurosci. 26: 12826-12837.
16. Wirenfeldt, M., L. Dissing-Olesen, A. Anne Babcock, M. Nielsen, M. Meldgaard, J. Zimmer, I. Azcoitia, R. G. Leslie, F. Dagnaes-Hansen, and B. Finsen. 2007. Population control of resident and immigrant microglia by mitosis and apoptosis. Am. J. Pathol. 171: 617-631.
17. Babcock, A. A., W. A. Kuziel, S. Rivest, and T. Owens. 2003. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 23: 7922-7930.
18. Fagan, A. M., and F. H. Gage. 1994. Mechanisms of sprouting in the adult central nervous system: cellular responses in areas of terminal degeneration and reinnervation in the rat hippocampus. Neuroscience 58: 705-725.
19. Frotscher, M., B. Heimrich, and T. Deller. 1997. Sprouting in the hippocampus is layer-specific. Trends Neurosci. 20: 218-223.
20. Savaskan, N. E., and R. Nitsch. 2001. Molecules involved in reactive sprouting in the hippocampus. Rev. Neurosci. 12: 195-215.
21. Khorooshi, R., A. A. Babcock, and T. Owens. 2008. NF-κB-driven STAT2 and CCL2 expression in astrocytes in response to brain injury. J. Immunol. 181: 7284-7291.
22. Babcock, A. A., H. Toft-Hansen, and T. Owens. 2008. Signaling through MyD88 regulates leukocyte recruitment after brain injury. J. Immunol. 181: 6481-6490.
23. Meraz, M. A., J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442.
24. Schmued, L. C., C. C. Stowers, A. C. Scallet, and L. Xu. 2005. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res. 1035: 24-31.
25. Seth, R. B., L. Sun, and Z. J. Chen. 2006. Antiviral innate immunity pathways. Cell Res. 16: 141-147.
26. Sedgwick, J. D., D. S. Riminton, J. G. Cyster, and H. Körner. 2000. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol. Today 21: 110-113. (Pubitemid 30122696)
27. Babcock, A., and T. Owens. 2003. Chemokines in experimental autoimmune encephalomyelitis and multiple sclerosis. Adv. Exp. Med. Biol. 520: 120-132.
28. Agrawal, S. M., L. Lau, and V. W. Yong. 2008. MMPs in the central nervous system: where the good guys go bad. Semin. Cell Dev. Biol. 19: 42-51.
29. Benveniste, E. N., and H. Qin. 2007. Type I interferons as anti-inflammatory mediators. Sci. STKE 2007: pe70.
30. Delhaye, S., S. Paul, G. Blakqori, M. Minet, F. Weber, P. Staeheli, and T. Michiels. 2006. Neurons produce type I interferon during viral encephalitis. Proc. Natl. Acad. Sci. USA 103: 7835-7840.
31. Floris, S., S. R. Ruuls, A. Wierinckx, S. M. van der Pol, E. Döpp, P. H. van der Meide, C. D. Dijkstra, and H. E. De Vries. 2002. Interferon-β directly influences monocyte infiltration into the central nervous system. J. Neuroimmunol. 127: 69-79.
32. Kimura, T., Y. Kadokawa, H. Harada, M. Matsumoto, M. Sato, Y. Kashiwazaki, M. Tarutani, R. S. Tan, T. Takasugi, T. Matsuyama, et al. 1996. Essential and non-redundant roles of p48 (ISGF3 γ) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells 1: 115-124. (Pubitemid 126673111)
33. Schmidt, H., J. Raasch, D. Merkler, F. Klinker, S. Krauss, W. Brück, and M. Prinz. 2009. Type I interferon receptor signalling is induced during demyelination while its function for myelin damage and repair is redundant. Exp. Neurol. 216: 306-311.
34. Okada, K., E. Kuroda, Y. Yoshida, U. Yamashita, A. Suzumura, and S. Tsuji. 2005. Effects of interferon-b on the cytokine production of astrocytes. J. Neuroimmunol. 159: 48-54. (Pubitemid 40126176)
35. Njenga, M. K., L. R. Pease, P. Wettstein, T. Mak, and M. Rodriguez. 1997. Interferon a/b mediates early virus-induced expression of H-2D and H-2K in the central nervous system. Lab. Invest. 77: 71-84.
36. Heine, S., J. Ebnet, S. Maysami, and M. Stangel. 2006. Effects of interferon-b on oligodendroglial cells. J. Neuroimmunol. 177: 173-180.
37. Clausen, B. H., K. L. Lambertsen, A. A. Babcock, T. H. Holm, F. Dagnaes- Hansen, and B. Finsen. 2008. Interleukin-1β and tumor necrosis factor-α are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J. Neuroinflammation 5: 46.
38. Jensen, M. B., I. V. Hegelund, N. D. Lomholt, B. Finsen, and T. Owens. 2000. IFNγ enhances microglial reactions to hippocampal axonal degeneration. J. Neurosci. 20: 3612-3621.
39. Majumder, S., L. Z. Zhou, P. Chaturvedi, G. Babcock, S. Aras, and R. M. Ransohoff. 1998. p48/STAT-1α-containing complexes play a predominant role in induction of IFN-γ-inducible protein, 10 kDa (IP-10) by IFN-γ alone or in synergy with TNF-α. J. Immunol. 161: 4736-4744.
40. Wu, C., Y. Ohmori, S. Bandyopadhyay, G. Sen, and T. Hamilton. 1994. Interferon- stimulated response element and NF κB sites cooperate to regulate double-stranded RNA-induced transcription of the IP-10 gene. J. Interferon Res. 14: 357-363.
41. Zhai, Y., B. Qiao, F. Gao, X. Shen, A. Vardanian, R. W. Busuttil, and J. W. Kupiec-Weglinski. 2008. Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion. Hepatology 47: 199-206.
42. Petry, H., L. Cashion, P. Szymanski, O. Ast, A. Orme, C. Gross, M. Bauzon, A. Brooks, C. Schaefer, H. Gibson, et al. 2006. Mx1 and IP-10: biomarkers to measure IFN-β activity in mice following gene-based delivery. J. Interferon Cytokine Res. 26: 699-705. (Pubitemid 44934109)
43. Stuve, O., S. Chabot, S. S. Jung, G. Williams, and V. W. Yong. 1997. Chemokineenhanced migration of human peripheral blood mononuclear cells is antagonized by interferon β-1b through an effect on matrix metalloproteinase-9. J. Neuroimmunol. 80: 38-46.
44. Agrawal, S., P. Anderson, M. Durbeej, N. van Rooijen, F. Ivars, G. Opdenakker, and L. M. Sorokin. 2006. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J. Exp. Med. 203: 1007-1019.
45. Veldhuis, W. B., J. W. Derksen, S. Floris, P. H. Van Der Meide, H. E. De Vries, J. Schepers, I. M. Vos, C. D. Dijkstra, L. J. Kappelle, K. Nicolay, and P. R. Bär. 2003. Interferon-b blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat. J. Cereb. Blood Flow Metab. 23: 1029-1039.
46. Veldhuis, W. B., S. Floris, P. H. van der Meide, I. M. Vos, H. E. de Vries, C. D. Dijkstra, P. R. Bär, and K. Nicolay. 2003. Interferon-β prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption. J. Cereb. Blood Flow Metab. 23: 1060-1069.
47. Liuzzi, G. M., T. Latronico, A. Fasano, G. Carlone, and P. Riccio. 2004. Interferon-β inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment. Mult. Scler. 10: 290-297.